1
|
De Moreuil C, Diot E, Agard C, Belhomme N, Lescoat A, Queyrel V, Tieulie N, Truchetet ME, Pugnet G, Berthier S, Smets P, Subran B, Lidove O, Keraen J, Mekinian A, Chatelus E, Pasquier E, Brenaut E, Rouvière B, Delplanque M, Lucier S, Courtois-Communier E, Devauchelle-Pensec V, Hachulla E. History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis. RMD Open 2024; 10:e003626. [PMID: 38176736 PMCID: PMC10773441 DOI: 10.1136/rmdopen-2023-003626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Accepted: 12/20/2023] [Indexed: 01/06/2024] Open
Abstract
BACKGROUND Vascular phenotype is associated with a poor prognosis in systemic sclerosis (SSc). The identification of its risk factors could facilitate its early detection. OBJECTIVES To explore risk factors for a vascular phenotype of SSc, among them a history of pre-eclampsia. METHODS This observational multicentre case-control study enrolled adult women fulfilling European Alliance of Associations for Rheumatology 2013 diagnosis criteria for SSc and having a pregnancy history≥6 months before SSc diagnosis in 14 French hospital-based recruiting centres from July 2020 to July 2022. Cases had specific vascular complications of SSc defined as history of digital ischaemic ulcers, pulmonary arterial hypertension, specific cardiac involvement or renal crisis. Women with SSc were included during their annual follow-up visit and filled in a self-administered questionnaire about pregnancy. A case report form was completed by their physician, reporting data on medical history, physical examination, clinical investigations and current medication. The main outcome was the presence/absence of a personal history of pre-eclampsia before SSc diagnosis, according to the validated pre-eclampsia questionnaire. RESULTS 378 women were included: 129 cases with a vascular phenotype and 249 matched controls. A history of pre-eclampsia was reported in 5 (3.9%) cases and 12 (4.8%) controls and was not associated with a vascular phenotype (OR=0.96, 95% CI 0.28 to 3.34, p=0.9). Besides, Rodnan skin score and disease duration≥5 years were risk factors for vascular phenotype. CONCLUSIONS In women with SSc and a pregnancy history≥6 months before SSc, a history of pre-eclampsia is not associated with a vascular phenotype.
Collapse
Affiliation(s)
- Claire De Moreuil
- Internal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France
- Inserm, Univ Brest, CHRU Brest, UMR 1304, GETBO, Brest, France
| | - Elizabeth Diot
- Internal Medicine, Regional University Hospital Centre Tours, Tours, France
| | - Christian Agard
- Internal Medicine, Nantes University Hospital, Nantes, France
- Nantes University, Pole Santé, Nantes, France
| | - Nicolas Belhomme
- Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France
- Institut de Recherche en Santé, Environnement et Travail (IRSET), UMRS 1085, Univ Rennes, Rennes, France
| | - Alain Lescoat
- Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France
- Institut de Recherche en Santé, Environnement et Travail (IRSET), UMRS 1085, Univ Rennes, Rennes, France
| | - Viviane Queyrel
- Internal Medicine, Nice Cote d'Azur University, Nice, France
| | - Nathalie Tieulie
- Rheumatology, Pasteur Hospital, Nice University Hospital, Nice Sophia Antipolis University, Nice, France
| | | | - Grégory Pugnet
- INSERM UMR1027, Toulouse, France
- Internal Medicine, Toulouse University Hospital, Toulouse, France
| | | | - Perrine Smets
- Internal Medicine Department, Centre Clermont-Ferrand University Hospital, Clermont-Ferrand, France
| | - Benjamin Subran
- Internal Medicine Department, La Croix Saint-Simon Hospital, Paris, France
| | - Olivier Lidove
- Internal Medicine Department, La Croix Saint-Simon Hospital, Paris, France
| | - Jeremy Keraen
- Internal Medicine, Hospital Centre Cornouaille, Quimper, France
| | - Arsène Mekinian
- Internal Medicine, DHUi2B, Saint Antoine Hospital, AP HP, Université Pierre et Marie Curie, Paris, France
| | | | - Elisabeth Pasquier
- Internal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France
| | | | - Bénedicte Rouvière
- UMR1227, Lymphocytes B et Autoimmunité, Université de Brest, INSERM, CHU de Brest, Brest, France
| | - Mathieu Delplanque
- Internal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France
| | - Sandy Lucier
- CIC 1412, INSERM, Brest University Hospital, Brest, France
| | | | | | - Eric Hachulla
- Internal Medicine Department, Centre de Référence des Maladies Auto-immunes Systémiques Rares Du Nord et Nord-Ouest de France, Lille, France
| |
Collapse
|